{"name":"MicuRx","slug":"micurx","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQazRZc2IyRUxtTTRfZGlxQnlnVmJKRUkzTHBkcEFDSmJxdURyR1Z6cHliYmtDWEhlNkNTMXNYUzJLY3FOOGRsNmhtQjZLcHlrczhNNFVJS1VTZFdkMW5GbEZQbV9pUVBEakpJdmowR3U1SXJBbzk1WjlzUXlVTzN6cWNmNGJxT0R2ZTEtamZyRFlxZ0ktaVkzbzFEc1pCUmppNk1OTzViUlRkUW5CQzV0QTZibXBMRUVfSHQ0RE9JUDFtMEpZY0xn?oc=5","date":"2025-01-02","type":"regulatory","source":"respiratory-therapy.com","summary":"FDA Grants Orphan Drug Designation to Antibiotic for NTM Infections - respiratory-therapy.com","headline":"FDA Grants Orphan Drug Designation to Antibiotic for NTM Infections - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZjF0dkhEVV9MREExbmFSRGxzRWh0WHRWTjFiN1IzbThLSGhIOG5FS0I1eGsxMU5OVXN2bjdEOUlITzF6MndPYWkteW8xdDFnMC1EWHdUaC1DZEtxeEFvOWJXUFFRLXZzYmNYT2J3RkM2dDZLdGwtNDNFMWw1ZWJqb2tkMG4tamVveXlqWURxZUFuQ2VlSXFuYUpXZm5GM0V3amlybTAyNXQwMmo3RV9tQ0tveENPdHRycm9yNFhuLW83bWs?oc=5","date":"2024-11-29","type":"regulatory","source":"BioPharma APAC","summary":"MicuRx Receives FDA QIDP and Fast Track Designation for Contezolid & Acefosamil - BioPharma APAC","headline":"MicuRx Receives FDA QIDP and Fast Track Designation for Contezolid & Acefosamil","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOcUx1RVpKRjVSSEhLMEN2ejNPczlCTm50Z0JjaW1RNFVCa1lYUndsVWt2Snd1Y0ZmMjJtQlNERjZ2SExsMHF6TDF5WlJkR01Jd3JrOUx6V3l6Ulo2S01ncHk4VHVxbjIyQk5GVTkxSmJZandaUzR5OWFPaWM5QmkyRnhtTGsxV21FVXRpTDlkbk5FOV9ILW1YMG0yWXQxRHhmT0V2UVJZaGd4OWxjVndSN1BSV0VhUmFZc25HTHpqaGRmM0JKOGN3Y1kyb1pOZEpwTl9PeDZyLVhTT0pYbTRB?oc=5","date":"2024-10-25","type":"trial","source":"PR Newswire","summary":"MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia - PR Newswire","headline":"MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOdVRtY2kzc2NmV3NCRm92a0RfVWJ4bDZoTThxSWdRUHRDT1NJeWllZjZablU3UmxFZmNxaGlSZi1NQTM5LW1maURJeHBvUDg0SnlQS1RtTlcwV3FJWlAxcW5lUkd3bXEtbmxFS3llTU5lay1TWUNqTlJrQkpMMUhpdnA2WldqcmlIcDM5d0g2ZXJ6ekN6c05fUUxQOC1xdjhacnJ1ZDRsQnZ5aWI5dFBIbXJzN3BLZmROTjFkYldkS1AxQ0RWYzZpdm1OTzlMdnFVRWRKUjV1T2pOa1phd3ExZk5NVnhfRTZlR0xNNW1ucjJ6aHdmT0ZEYjgtVW5rWV9K?oc=5","date":"2024-10-08","type":"trial","source":"PR Newswire","summary":"MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections - PR Newswire","headline":"MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFA4c1RzNDJpRFVDSFQtblVQRXdVVWpBZzBmNC1ybURhR0JoTDA2RUY3dWpKLXJVTXQ1VzdkeG9MZ3BQTzJTd3hxYVFvZzJlQUMybkk0MFVNMFlPTTFWcVJ1WVFZZmlmbnpiRXVRX2Q1RzVZaG52SXVzX0tXQzFPZw?oc=5","date":"2024-06-07","type":"trial","source":"Clinical Trials Arena","summary":"MicuRx’s Phase I trial of antibacterial drug meets expected goals - Clinical Trials Arena","headline":"MicuRx’s Phase I trial of antibacterial drug meets expected goals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPOWZ5Z0k5MlNjX0h5NE1TMXV4OEI1Y3RuWWFfVGZBNzkwR3R0Nm1TczhjQ1lzNmtIb3FacUhvNlluWEtFTEpTbTBwR19SRHE3Ymg5cmk4aWdSdjFDMWVPT25TVWdTMXpZYUhoci02SlZ5ZjRIczVESXFyNUZMRi1wc0FWS21WN2pNVVF2cE5Rd3dHUGwzdnRuR0ZnNW5TNTBaRVc0Q0NTR3ZWcDJJNklPOVZNMGxKbUY4Snd2Zl84ZGt3UUQ3TXVQQnlfUExPbmFEN0ZXeGxVR3N1bW5QR0xRQ3VLdFNQZw?oc=5","date":"2023-02-08","type":"pipeline","source":"PR Newswire","summary":"Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc. - PR Newswire","headline":"Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPVkxyYmE0bm1uRnVjcVdTWjdKOV8taS1LVmR1NU5zbzlNZUhWSkkteklKVU80djItS29hZDhKSC1kUnVvYURuc0tNeTZjdV9OYWp2dWg5bG9Sa3Z4SWNBbk5pNy1sTDRhMW0xSk1PWXJhV2p2OUhHS0pwNGcxM2dOVktnbzI4SjJHTGRyVVFjT0VHTFV5TFlETzNDUUFvdlZfRmc?oc=5","date":"2013-02-19","type":"pipeline","source":"Asian Scientist Magazine","summary":"Gut Microbes Could Influence Survival In Melamine Scandal - Asian Scientist Magazine","headline":"Gut Microbes Could Influence Survival In Melamine Scandal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}